Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Augenklinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Forschungsprojekte
Ergebnisse pro Seite:  10

2015 - 2018

Lampalizumab GX29185: A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF LAMPALIZUMAB ADMINISTERED INTRAVITREALLY TO PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
  • Dr. Katharina,
  • PD Dr. Katrin

2015 - 2017

FishUP - Sensimed Triggerfish Utility Program
  • PD Dr. Katrin

2015 - 2016

Ganfort (201450): A phase IV study on the changes in ocular signs and symptoms in patients with ocular hypertension or open-angle glaucoma switched from Ganfort® eye drops (bimatoprost 0.03%/timolol 0.5%) to Taptiqom® eye drops (tafluprost 0.0015%/timolol 0.5%).
  • PD Dr. Katrin

2015 - 2016

IRISS: AN OPEN LABEL, REGISTRY STUDY OF THE SAFETY OF ILUVIEN® 190 MICROGRAMS INTRAVITREAL IMPLANT IN APPLICATOR
  • Prof. Dr. Norbert

2015 - 2017

CyPass TMI-13-01: RANDOMIZED PROSPECTIVE CLINICAL EVALUATION OF THE SAFETY AND EFFECTIVENESS OF VISCO-ASSISTED CYPASS IMPLANTATION IN PATIENTS WITH OPEN ANGLE GLAUCOMA
  • Prof. Dr. Norbert

2015 - 2017

AQUA 17850: Open-label Phase-4 study to examine the change of vision-related quality of life in subjects with diabetic macular edema (DME) during treatment with intravitreal injections of 2 mg aflibercept according to EU label for the first year of treatment
  • Dr. Katharina,
  • PD Dr. Katrin

2015 - 2017

Synteract HCR: ISTH0036 in trabeculectomy
  • PD Dr. Katrin

2015 - 2022

Lynx (A6111144): LONG-TERM SURVEILLANCE STUDY OF LATANOPROST TO MONITOR HYPERPIGMENTATION CHANGES IN THE EYE IN PEDIATRIC POPULATIONS
  • PD Dr. Katrin

2015 - 2017

Ophthotech OPH1004: A PHASE 3 RANDOMIZED, DOUBLE-MASKED, CONTROLLED TRIAL TO ESTABLISH THE SAFETY AND EFFICACY OF INTRAVITREOUS ADMINISTRATION OF FOVISTATM (ANTI PDGF-B PEGYLATED APTAMER) ADMINISTERED IN COMBINATION WITH EITHER AVASTIN® OR EYLEA® COMPARED TO AVASTIN® OR EYLEA® MONOTHERAPY IN SUBJECTS WITH SUBFOVEAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
  • PD Dr. Katrin

2015 - 2017

Molecular biomarkers in experimental glaucoma and their functional relevance for apoptotic and regeneration-related signaling pathways
  • PD Dr. Verena